- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | FYL/NFYL Fentarnyl/Norfentanyl Urine Rapid Test Panel |
| Catalog No. | ID-HYW-0004 |
| Description | The HIGHTOP-fentanyl/norfentanyl urine rapid test panel is a chromatographic immunoassay designed for the qualitative detection of fentanyl and its metabolite norfentanyl in human urine, offering a fast and accurate indication of fentanyl use or exposure. |
| Certification | FDA |
| Species Characteristics | Human |
| Detection Principle | Immunochromatographic method |
| Specificity | Recognize fentanyl/norfentanyl in urine |
| Sample Type | Urine |
| Application | It can be used for immediate in vitro detection of fentanyl/norfentanyl. |
| Storage | Store at 4°C |
| Operating Temperature | Operate at 4-30°C |
| Transportation Condition | Transportation at room temperature |
| Cut Off | FYL 1 ng/mL; NFYL 5 ng/mL |
| Product Introduction | Fentanyl is a potent synthetic opioid involved in a significant number of overdose deaths. Its primary urinary metabolite, norfentanyl, is a key target for detection. This rapid test panel is a lateral flow immunoassay (LFA) device designed for the qualitative detection of fentanyl and norfentanyl in human urine at clinically relevant cut-off concentrations (typically 5-10 ng/mL for fentanyl). It provides a visual result (colored lines) within minutes, making it suitable for use in clinical, workplace, forensic, or public health settings where rapid screening is essential. |
| Product Application | • Point-of-care (POC) screening for fentanyl use in emergency departments, rehab clinics, and parole settings. • Workplace drug testing programs. • Forensic toxicology initial screening. • Public health initiatives to monitor substance abuse trends. |
| Product Advantages | • Dual-Target Detection: Simultaneously screens for both the parent drug (fentanyl) and its major metabolite (norfentanyl), increasing the detection window and reducing the chance of false negatives. • Rapid Visual Result: Delivers easy-to-interpret results in approximately 5-8 minutes, enabling immediate decision-making without the need for instrumentation. • Built-In Controls: Each cassette contains a procedural Control (C) line to confirm the test has functioned correctly, ensuring test validity and user confidence. • CLIA-Waived Simplicity: Designed for simplicity with minimal steps (add urine, wait, read), allowing it to be performed by personnel with minimal training in non-laboratory settings. |
For in vitro diagnostic use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
